Clinical trial
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With…
NCT00434161 · Swedish Orphan Biovitrum, Industry · Completed
Key facts
| NCT number | NCT00434161 |
|---|---|
| Title | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma |
| Official title | A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin for Reduction in Severity of Oral Mucositis in Subjects With Multiple Myeloma Receiving Melphalan Followed by Autologous Blood Stem Cell Transplantation |
| Lead sponsor | Swedish Orphan Biovitrum, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Palifermin before only, Placebo, Palifermin before and after |
| Enrollment | 281 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | May 1, 2012 |
| First posted | Feb 12, 2007 |
| Last update posted | Mar 30, 2015 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: